CD276 and head and neck squamous cell carcinoma: A blockade of CD276 (B7-H3) checkpoint molecules on the surface of human head and neck squamous cell carcinoma (HNSCC) CSCs provided T-cell-dependent elimination of these cells, inhibiting tumor growth and metastasis formation in the HNSCC mouse model in vivo [66].